KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Total Liabilities (2016 - 2025)

Pacira BioSciences has reported Total Liabilities over the past 16 years, most recently at $571.8 million for Q4 2025.

  • Quarterly results put Total Liabilities at $571.8 million for Q4 2025, down 26.23% from a year ago — trailing twelve months through Dec 2025 was $571.8 million (down 26.23% YoY), and the annual figure for FY2025 was $571.8 million, down 26.23%.
  • Total Liabilities for Q4 2025 was $571.8 million at Pacira BioSciences, roughly flat from $570.4 million in the prior quarter.
  • Over the last five years, Total Liabilities for PCRX hit a ceiling of $1.3 billion in Q4 2021 and a floor of $570.4 million in Q3 2025.
  • Median Total Liabilities over the past 5 years was $761.5 million (2023), compared with a mean of $795.0 million.
  • Biggest five-year swings in Total Liabilities: skyrocketed 105.39% in 2021 and later crashed 36.09% in 2023.
  • Pacira BioSciences' Total Liabilities stood at $1.3 billion in 2021, then tumbled by 32.62% to $906.2 million in 2022, then dropped by 22.28% to $704.3 million in 2023, then rose by 10.07% to $775.2 million in 2024, then dropped by 26.23% to $571.8 million in 2025.
  • The last three reported values for Total Liabilities were $571.8 million (Q4 2025), $570.4 million (Q3 2025), and $779.5 million (Q2 2025) per Business Quant data.